Green Fluorescent Protein Retroviral Vector

Generation of High-Titer Producer Cells and Virus Supernatant
  • Wolfgang Uckert
  • Lene Pedersen
  • Walter Günzburg
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 35)


Genes-encoding marker proteins, which are easily assayable, are useful to monitor cell lineage, gene expression, or promoter activities. In gene-transfer technology such marker genes allow a direct and simple detection of successfully transduced cells. The detection of marker gene products such as β-galactosidase (β-gal), chloramphenicol acetyltransferase (CAT), alkaline phosphatase, or luciferase involves either cell fixation, which kills the cells or antibody-mediated detection, which is time consuming. Drug-resistance genes such as neomycin, puromycin, hygromycin, or zeocin allow a positive selection of transduced cells, but require days to weeks of growth in selective media. Moreover, these genes can change the growth characteristics of the transduced cells through terminal differentiation or can interfere with the expression of the gene of interest (1). Therefore, a marker gene system that provides timely, accurate, and nontoxic detection of successfully transduced living cells would be of great advantage. One interesting candidate gene that fulfills these requirements is the gene-encoding green fluorescent protein (GFP). It was originally isolated from the jellyfish Aquorea victoria. The GFP cDNA consists of 730 bp, which encode a 238 amino acid protein with a molecular weight of 27 kD (2). Wild-type GFP emits a vibrant green fluorescence upon exposure to blue light (450-490 nm). The signal is detectable by fluorescence microscopy and fluorescence-activated cell sorting (FACS) (3). Because the fluorescence of wild-type GFP after excitation is not strong enough for many applications, different variants of GFP have been developed. In one such variant, a point mutation was introduced at amino acid 65 (GFP-S65T) leading to a “red-shifted” excitation maximum with an approximately five-fold stronger fluorescent intensity (4). In a further variant, the “red-shifted” GFP was “humanized” by the introduction of numerous silent mutations that alter the codons to those more commonly used in human genes resulting in the improved translation of the gene (5-7). An additional point mutation at amino acid 64 in which phenylalanine was altered to leucine (F64L) further enhances gene expression (8). GFP has been expressed without cytotoxic effects in different organisms and is of special interest as a marker for monitoring cell lines and gene expression (3). The application of GFP in gene-transfer protocols allows the simple detection of transduced cells and offers the possibility for immediate enrichment of viable transduced cells by FACS (3,9,10). This is of great interest in gene transfer into poorly transducable cells, e.g., hematopoietic stem and progenitor cells.


Green Fluorescent Protein Virus Titer Packaging Cell Packaging Cell Line Virus Dilution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Valera, A., Perales, J. C., Hatzoglou, M., and Bosch, F. (1994) Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Human Gene Ther. 5, 449–456.CrossRefGoogle Scholar
  2. 2.
    Prasher, D. C., Eckenrode, V. K., Ward, W. W., Prender-Gast, F. G., and Cormier, M. J. (1992) Primary structure of the Aquorea victoria green fluorescent protein. Gene 111, 229–233.PubMedCrossRefGoogle Scholar
  3. 3.
    Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W., and Prasher, D. C. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802–805.PubMedCrossRefGoogle Scholar
  4. 4.
    Heim, R., Cubitt, A. B., and Tsien, R. Y. (1995) Improved green fluorescence. Nature 373, 663–664.PubMedCrossRefGoogle Scholar
  5. 5.
    Levy, J. P., Muldoon, R. R., Zolotukhin, S., and Link, C. J. (1996) Retroviral transfer and expression of a humanized, red shifted green fluorescent protein into human tumor cells. Nature Biotechnol. 14, 610–614.CrossRefGoogle Scholar
  6. 6.
    Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., and Muzyczka, N. (1996) A “humanized” green fluorescent protein cDNA adapted for high level expression in mammalian cells. J. Virol. 70, 4646–4654.PubMedGoogle Scholar
  7. 7.
    Muldoon, R. R., Levy, J. P., Kain, S. R., Kitts, P. A., and Link Jr., C. J. (1997) Tracking and quantitation of retroviral-mediated transfer using a completely humanized, red shifted green fluorescent protein gene. BioTechniques 22, 162–165.PubMedGoogle Scholar
  8. 8.
    Cormack, B. P., Valdivia, R. H., and Falkow, S. (1996) FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33–38.PubMedCrossRefGoogle Scholar
  9. 9.
    Kain, S. and Ganguly, S. (1995) Use of fusion genes in mammalian transfection. Overview of genetic reporter systems, in Current Protocols in Molecular Biology (Ausubel, M., Rent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., Struhl, K., eds.), Wiley, New York, unit 9.6.Google Scholar
  10. 10.
    Dunbar, C. E. and Emmons, R. V. B. (1994) Gene transfer into hematopoietic progenitor and stem cells: progress and problems. Stem Cell 12, 563–576.CrossRefGoogle Scholar
  11. 11.
    Riviere, I. and Sadelain, M. (1997) Methods for the construction of retroviral vectors and the generation of high-titer producers, in Methods in Molecular Medicine: Gene Therapy Protocols (Robbins, P. D., ed.), Humana, Totowa, NJ, pp. 59–78.Google Scholar
  12. 12.
    Riggs, J. L., Mcallister, R. M., and Lennette, E. H. (1974) Immunofluorescent studies of RD-114 virus replication. J. gen. Virol. 25, 21–29.PubMedCrossRefGoogle Scholar
  13. 13.
    Klein, D., Indraccolo, S., von Rombs, K., Amadori, A., Salmons, B., and Günzburg, W. H. (1997) Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker. Gene Ther. 4, 1256–1260.PubMedCrossRefGoogle Scholar
  14. 14.
    Cossett, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A., and Collins, M. K. (1995) High-titer packaging cells producing recombinant retrovirus resistant to human serum. J. Virol. 69, 7430–7436.Google Scholar
  15. 15.
    Kaptein, L. C. M., Greijer, A. E., Valerio, D., and van Beusechem, V. W. (1997) Optimized conditions for the production of recombinant amphotropic retroviral vector preparations. Gene Ther. 4, 172–176.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Wolfgang Uckert
    • 1
  • Lene Pedersen
    • 2
  • Walter Günzburg
    • 3
  1. 1.Max-Delbrück-Center for Molecular MedicineBerlinGermany
  2. 2.Department of Molecular and Structural BiologyUniversity of AarhusAarhusDenmark
  3. 3.Institute of VirologyUniversity of Veterinary SciencesViennaAustria

Personalised recommendations